![Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases? | Nature Reviews Neurology Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases? | Nature Reviews Neurology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fncpneuro0357/MediaObjects/41582_2006_Article_BFncpneuro0357_Fig1_HTML.jpg)
Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases? | Nature Reviews Neurology
![Overview of sleep disturbances and their management in Parkinson plus disorders - Journal of the Neurological Sciences Overview of sleep disturbances and their management in Parkinson plus disorders - Journal of the Neurological Sciences](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/0331379c-784b-420c-8144-8ede6bcb06b1/gr1_lrg.jpg)
Overview of sleep disturbances and their management in Parkinson plus disorders - Journal of the Neurological Sciences
![Urinary symptoms in patients with Parkinson's disease and progressive supranuclear palsy: Urodynamic findings and management of bladder dysfunction Gupta A, Rashmi Krishnan U K, Nageshkumar S, Pal PK, Khanna M, Taly AB - Urinary symptoms in patients with Parkinson's disease and progressive supranuclear palsy: Urodynamic findings and management of bladder dysfunction Gupta A, Rashmi Krishnan U K, Nageshkumar S, Pal PK, Khanna M, Taly AB -](https://www.annalsofian.org/articles/2019/22/4/images/AnnIndianAcadNeurol_2019_22_4_432_243806_t1.jpg)
Urinary symptoms in patients with Parkinson's disease and progressive supranuclear palsy: Urodynamic findings and management of bladder dysfunction Gupta A, Rashmi Krishnan U K, Nageshkumar S, Pal PK, Khanna M, Taly AB -
![PDF) Progressive supranuclear palsy – parkinsonism predominant (PSP-P) – a clinical challenge at the boundaries of PSP and Parkinson's Disease (PD) PDF) Progressive supranuclear palsy – parkinsonism predominant (PSP-P) – a clinical challenge at the boundaries of PSP and Parkinson's Disease (PD)](https://i1.rgstatic.net/publication/339461125_Progressive_supranuclear_palsy_-_parkinsonism_predominant_PSP-P_-_a_clinical_challenge_at_the_boundaries_of_PSP_and_Parkinson's_Disease_PD/links/5e6e38c2a6fdccf994cb761b/largepreview.png)
PDF) Progressive supranuclear palsy – parkinsonism predominant (PSP-P) – a clinical challenge at the boundaries of PSP and Parkinson's Disease (PD)
![Progressive Supranuclear Palsy Treatment Market Estimated to Reach A Valuation Of US$ 20.68 Million By 2027 – with AbbVie Inc., Acorda Therapeutics Inc., Biogen Inc., Bristol-Myers Squibb Co., Merck & Co. Inc., etc | Medgadget Progressive Supranuclear Palsy Treatment Market Estimated to Reach A Valuation Of US$ 20.68 Million By 2027 – with AbbVie Inc., Acorda Therapeutics Inc., Biogen Inc., Bristol-Myers Squibb Co., Merck & Co. Inc., etc | Medgadget](https://www.medgadget.com/wp-content/uploads/2020/12/progressive-supranuclear-palsy-treatment-market-scaled.jpg)
Progressive Supranuclear Palsy Treatment Market Estimated to Reach A Valuation Of US$ 20.68 Million By 2027 – with AbbVie Inc., Acorda Therapeutics Inc., Biogen Inc., Bristol-Myers Squibb Co., Merck & Co. Inc., etc | Medgadget
![Non motor symptoms in progressive supranuclear palsy: prevalence and severity | npj Parkinson's Disease Non motor symptoms in progressive supranuclear palsy: prevalence and severity | npj Parkinson's Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41531-017-0037-x/MediaObjects/41531_2017_37_Fig1_HTML.jpg)
Non motor symptoms in progressive supranuclear palsy: prevalence and severity | npj Parkinson's Disease
![How to spot ocular abnormalities in progressive supranuclear palsy? A practical review | Translational Neurodegeneration | Full Text How to spot ocular abnormalities in progressive supranuclear palsy? A practical review | Translational Neurodegeneration | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40035-019-0160-1/MediaObjects/40035_2019_160_Fig1_HTML.png)
How to spot ocular abnormalities in progressive supranuclear palsy? A practical review | Translational Neurodegeneration | Full Text
![Mutations in bassoon in individuals with familial and sporadic progressive supranuclear palsy-like syndrome | Scientific Reports Mutations in bassoon in individuals with familial and sporadic progressive supranuclear palsy-like syndrome | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-018-19198-0/MediaObjects/41598_2018_19198_Fig1_HTML.jpg)
Mutations in bassoon in individuals with familial and sporadic progressive supranuclear palsy-like syndrome | Scientific Reports
Methylphenidate in Progressive Supranuclear Palsy [PSP] – Old drug, New Indications? - MDS Abstracts
![Progressive Supranuclear Palsy Treatment Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027 Progressive Supranuclear Palsy Treatment Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027](http://www.researchandmarkets.com/product_images/11120/11120712_500px_jpg/progressive_supranuclear_palsy_treatment_market.jpg)
Progressive Supranuclear Palsy Treatment Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
![Diagnostic accuracy of Magnetic Resonance Parkinsonism Index in differentiating progressive supranuclear palsy from Parkinson's disease and controls in Indian patients Diagnostic accuracy of Magnetic Resonance Parkinsonism Index in differentiating progressive supranuclear palsy from Parkinson's disease and controls in Indian patients](https://neurologyindia.com/articles/2016/64/2/images/ni_2016_64_2_239_177611_t3.jpg)